Knott David M Jr Roivant Sciences Ltd. Transaction History
Knott David M Jr
- $251 Million
- Q2 2024
A detailed history of Knott David M Jr transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Knott David M Jr holds 63,000 shares of ROIV stock, worth $716,310. This represents 0.27% of its overall portfolio holdings.
Number of Shares
63,000
Previous 53,200
18.42%
Holding current value
$716,310
Previous $561,000
18.72%
% of portfolio
0.27%
Previous 0.2%
Shares
3 transactions
Others Institutions Holding ROIV
# of Institutions
308Shares Held
496MCall Options Held
989KPut Options Held
1.15M-
Sb Investment Advisers (Uk) LTD London, X071.4MShares$811 Million6.97% of portfolio
-
Viking Global Investors LP69.2MShares$786 Million2.91% of portfolio
-
Qvt Financial LP New York, NY66.7MShares$759 Million72.99% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$402 Million0.01% of portfolio
-
Morgan Stanley New York, NY29.3MShares$333 Million0.02% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $8.01B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...